Authors: SZABADI E BRADSHAW CM BOSTON PF LANGLEY RW

Citation: E. Szabadi et al., THE HUMAN PHARMACOLOGY OF REBOXETINE, Human psychopharmacology, 13, 1998, pp. 3-12

Authors: BRUNELLO N RAGAGNI G SZABADI E BRADSHAW CM BOSTON PF LANGELY RW HINDMARCH I BAN TA GASZNER P AGUGLIA E BATISTA R COSTILLO A LIPSCEY A MACHER JP RUIZ AT VERGARA L

Citation: N. Brunello et al., THE ROLE OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR,IN THE TREATMENT OF DEPRESSION - PROCEEDINGS OF A SATELLITE SYMPOSIUMTO THE EUROPEAN CONGRESS OF THE WORLD-PSYCHIATRIC-ASSOCIATION, GENEVA, 1997 - DISCUSSION, Human psychopharmacology, 13, 1998, pp. 42-44

Authors: DURSUN SM BOSTON PF ZAFAR R REVELEY MA

Citation: Sm. Dursun et al., LOW SERUM-CHOLESTEROL AND TREATMENT-RESISTANCE IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 2-2

Authors: BOSTON PF DURSUN SM REVELEY MA

Citation: Pf. Boston et al., CHOLESTEROL AND MENTAL DISORDER, British Journal of Psychiatry, 169(6), 1996, pp. 682-689

Authors: BOSTON PF DURSUN SM ZAFAR R REVELEY MA

Citation: Pf. Boston et al., SERUM-CHOLESTEROL AND TREATMENT-RESISTANCE IN SCHIZOPHRENIA, Biological psychiatry, 40(6), 1996, pp. 542-543

Authors: BOSTON PF DURSUN SM REVELEY MA

Citation: Pf. Boston et al., CHOLESTEROL AND VIOLENT DEATH - OTHER STUDIES EXIST, BMJ. British medical journal, 309(6963), 1994, pp. 1228-1228